Rebecca Miller in Santa Barbara, California

Home California Santa Barbara

Rebecca Miller has Dermatology as her primary medical specialty. Their primary office is: 334 S Patterson Ave in Santa Barbara, California. There is an additional office location, for a total of two, for Rebecca Miller that can be viewed further down. They attended University Of Southern California Keck School Of Medicine and graduated in 1994 (around 30 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Rebecca D Miller Office Phone and Directions

Rebecca Miller
334 S Patterson Ave
Santa Barbara, California 93111
805-964-1514

Patient Ratings
Please rate your experience with Rebecca Miller below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 805-964-1514

Enter a starting address:

Healthcare Info for Rebecca Miller

Medical School: University Of Southern California Keck School Of Medicine
Graduation Year: 1994
The Primary Medical Specialty for Rebecca Miller is listed as: Dermatology
Approximate Years of Experience: 30
PAC (PECOS ID)#: 4183704240
NPI #: 1043214026
NPI Created On: 06/08/2005
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207N00000X
License Number:
A55231
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Tangential biopsy of single skin lesion
Tangential biopsy of additional skin lesion
Removal of growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs
Injection of up to 7 skin growths
Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs
Destruction of skin growth
Destruction of 2-14 skin growths
Destruction of 15 or more skin growths
Destruction of up to 14 skin growths
Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs
Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs
Destruction of malignant growth (2.1 to 3.0 centimeters) of trunk, arms, or legs
Destruction of malignant growth (0.6 to 1.0 centimeters) of scalp, neck, hands, feet, or genitals
Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals
Destruction of malignant growth (0.5 centimeters or less) of face, ears, eyelids, nose, lips, or mouth
Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth
Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth
Pathology examination of tissue using a microscope, moderately low complexity
Pathology examination of tissue using a microscope, intermediate complexity
New patient office or other outpatient visit, typically 30 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809605451

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: INFLAMMATION AND IMMUNOLOGY

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01

Payments Total: $62

Number of Payments:: 1